{
  "@context": "http://id.who.int/icd/contexts/contextForLinearizationEntity.json",
  "@id": "http://id.who.int/icd/release/11/2024-01/mms/2073226578",
  "parent": [
    "http://id.who.int/icd/release/11/2024-01/mms/110923694"
  ],
  "browserUrl": "https://icd.who.int/browse/2024-01/mms/en#2073226578",
  "code": "2A40",
  "source": "http://id.who.int/icd/entity/2073226578",
  "classKind": "category",
  "postcoordinationScale": [
    {
      "@id": "http://id.who.int/icd/release/11/2024-01/mms/2073226578/postcoordinationScale/histopathology",
      "axisName": "http://id.who.int/icd/schema/histopathology",
      "requiredPostcoordination": "false",
      "allowMultipleValues": "NotAllowed",
      "scaleEntity": [
        "http://id.who.int/icd/release/11/2024-01/mms/2136151544",
        "http://id.who.int/icd/release/11/2024-01/mms/1358305224",
        "http://id.who.int/icd/release/11/2024-01/mms/720968487"
      ]
    },
    {
      "@id": "http://id.who.int/icd/release/11/2024-01/mms/2073226578/postcoordinationScale/hasManifestation",
      "axisName": "http://id.who.int/icd/schema/hasManifestation",
      "requiredPostcoordination": "false",
      "allowMultipleValues": "AllowAlways",
      "scaleEntity": [
        "http://id.who.int/icd/release/11/2024-01/mms/322466810"
      ]
    },
    {
      "@id": "http://id.who.int/icd/release/11/2024-01/mms/2073226578/postcoordinationScale/hasSeverity",
      "axisName": "http://id.who.int/icd/schema/hasSeverity",
      "requiredPostcoordination": "false",
      "allowMultipleValues": "NotAllowed",
      "scaleEntity": [
        "http://id.who.int/icd/release/11/2024-01/mms/1863636238",
        "http://id.who.int/icd/release/11/2024-01/mms/885826145",
        "http://id.who.int/icd/release/11/2024-01/mms/1746207012",
        "http://id.who.int/icd/release/11/2024-01/mms/303697349"
      ]
    }
  ],
  "title": {
    "@language": "en",
    "@value": "Chronic myelomonocytic leukaemia"
  },
  "definition": {
    "@language": "en",
    "@value": "A myelodysplastic/myeloproliferative neoplasm which is characterised by persistent monocytosis, absence of a Philadelphia chromosome and BCR/ABL1 fusion gene, fewer than 20 percent blasts in the bone marrow and blood, often myelodysplasia, and absence of PDGFRA or PDGFRB rearrangement."
  },
  "inclusion": [
    {
      "label": {
        "@language": "en",
        "@value": "Chronic monocytic leukaemia"
      }
    }
  ],
  "exclusion": [
    {
      "label": {
        "@language": "en",
        "@value": "Myeloid/lymphoid neoplasm associated with PDGFRA rearrangement"
      },
      "foundationReference": "http://id.who.int/icd/entity/833355630",
      "linearizationReference": "http://id.who.int/icd/release/11/2024-01/mms/833355630"
    },
    {
      "label": {
        "@language": "en",
        "@value": "Myeloid neoplasm associated with PDGFRB rearrangement"
      },
      "foundationReference": "http://id.who.int/icd/entity/625932159",
      "linearizationReference": "http://id.who.int/icd/release/11/2024-01/mms/625932159"
    }
  ],
  "indexTerm": [
    {
      "label": {
        "@language": "en",
        "@value": "Chronic myelomonocytic leukaemia"
      }
    },
    {
      "label": {
        "@language": "en",
        "@value": "CMML - [chronic myelomonocytic leukaemia]"
      }
    },
    {
      "label": {
        "@language": "en",
        "@value": "chronic myelomonocytic leukaemia without mention of remission"
      }
    },
    {
      "label": {
        "@language": "en",
        "@value": "Chronic monocytic leukaemia"
      }
    },
    {
      "label": {
        "@language": "en",
        "@value": "chronic monocytoid leukaemia"
      }
    },
    {
      "label": {
        "@language": "en",
        "@value": "Chronic myelomonocytic leukaemia in complete remission"
      },
      "foundationReference": "http://id.who.int/icd/entity/1182698447"
    },
    {
      "label": {
        "@language": "en",
        "@value": "Chronic myelomonocytic leukaemia with eosinophilia"
      },
      "foundationReference": "http://id.who.int/icd/entity/1821609913"
    },
    {
      "label": {
        "@language": "en",
        "@value": "CMML - [chronic myelomonocytic leukaemia] with eosinophilia"
      },
      "foundationReference": "http://id.who.int/icd/entity/1821609913"
    },
    {
      "label": {
        "@language": "en",
        "@value": "Chronic myelomonocytic leukaemia Type 1"
      },
      "foundationReference": "http://id.who.int/icd/entity/1404984529"
    },
    {
      "label": {
        "@language": "en",
        "@value": "CMML-1 - [chronic myelomonocytic leukaemia Type 1]"
      },
      "foundationReference": "http://id.who.int/icd/entity/1404984529"
    },
    {
      "label": {
        "@language": "en",
        "@value": "Chronic myelomonocytic leukaemia Type 2"
      },
      "foundationReference": "http://id.who.int/icd/entity/917064474"
    },
    {
      "label": {
        "@language": "en",
        "@value": "CMML-2 - [chronic myelomonocytic leukaemia Type 2]"
      },
      "foundationReference": "http://id.who.int/icd/entity/917064474"
    }
  ]
}